{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T23:08:51Z","timestamp":1785020931886,"version":"3.55.0"},"reference-count":64,"publisher":"International Union Against Tuberculosis and Lung Disease","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJTLD Open"],"accepted":{"date-parts":[[2025,9,29]]},"published-print":{"date-parts":[[2025,12]]},"abstract":"<jats:title>SUMMARY<\/jats:title>\n                  <jats:sec>\n                    <jats:title>BACKGROUND<\/jats:title>\n                    <jats:p>While antimicrobial stewardship (AMS) is essential for combating antimicrobial resistance (AMR), TB-specific AMS strategies remain poorly defined.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>METHODS<\/jats:title>\n                    <jats:p>An international panel of 62 experts participated in a Delphi process. Using a 5-point Likert scale (5 = strong agreement; 1 = strong disagreement), participants evaluated 10 draft clinical standards developed by a core coordination team. A standard was adopted if \u226590% of respondents rated it three or higher, according to a predefined consensus threshold.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESULTS<\/jats:title>\n                    <jats:p>All 10 standards reached the consensus threshold and were adopted: Standard 1, integration of TB into national AMR action plans; Standard 2, implementation of TB surveillance systems; Standard 3, education of health care providers, individuals affected by TB, and the public; Standard 4, integration of TB into AMS activities; Standard 5, establishment of expert consultation services; Standard 6, targeted testing and preventive treatment for individuals at risk for TB; Standard 7, access to timely and comprehensive drug susceptibility testing; Standard 8, prioritisation of efficacy, safety, and resistance prevention in TB treatment regimens; Standard 9, clinical and microbiological monitoring of treatment response; and Standard 10, assessment of adherence, drug exposure, and resistance in treatment failure.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSION<\/jats:title>\n                    <jats:p>These clinical standards aim to support clinicians, programme managers, and public health authorities in implementing effective, TB-specific AMS strategies.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.5588\/ijtldopen.25.0522","type":"journal-article","created":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T11:08:01Z","timestamp":1765796881000},"page":"716-726","source":"Crossref","is-referenced-by-count":3,"title":["Clinical standards for antimicrobial stewardship in TB care"],"prefix":"10.5588","volume":"2","author":[{"given":"T.T.","family":"Brehm","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O.W.","family":"Akkerman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Sotgiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Tiberi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.-C.","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Dheda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Duarte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Vambe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Z.F.","family":"Udwadia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Chesov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Mendelson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.M.","family":"Iswari Saktiawati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"van Ingen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.O.","family":"Eyuboglu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"T\u00e4ngd\u00e9n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.N.","family":"Quang Vo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Riccardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Moschos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.S.","family":"Friedland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Lillebaek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.J.","family":"Chandy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.A.","family":"Caminero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Thwaites","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Gandra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Thursky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.A.","family":"George","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O.","family":"Konstantynovska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Fatima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.-J.","family":"Yim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Kwak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.D.","family":"Olaru","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.H.","family":"Gillespie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y.","family":"Kherabi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.H.","family":"Perl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Gr\u00f8nningen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Rodrigues","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Bjerrum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Bange","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Cox","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.M.","family":"Cirillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Saluzzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.L.","family":"Hara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Wagner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Ismail","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.J.","family":"Sloan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.","family":"Eshun-Wilsonova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Cantero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Vasankari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Mandalakas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Kay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Ness","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.M.","family":"Torrico","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"G\u00fcnther","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Kuksa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Guglielmetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.L.","family":"Garc\u00eda-Basteiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.B.","family":"Marks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Pulcini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Lange","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"3554","published-online":{"date-parts":[[2025,12,1]]},"reference":[{"key":"2026011502220648000_2.12.716.1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(24)01867-1"},{"key":"2026011502220648000_2.12.716.2","unstructured":"World Health Organization . WHO bacterial priority pathogens list, 2024: bacterial pathogens of public health importance to guide research, development and strategies to prevent and control antimicrobial resistance. Geneva: WHO, 2024."},{"key":"2026011502220648000_2.12.716.3","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmi.2017.08.026"},{"key":"2026011502220648000_2.12.716.4","doi-asserted-by":"publisher","DOI":"10.1086\/665010"},{"issue":"3","key":"2026011502220648000_2.12.716.5","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.cmi.2024.10.013","article-title":"Why don\u2019t we talk about tuberculosis stewardship?","volume":"31","author":"Riccardi","year":"2025","journal-title":"Clin Microbiol Infect"},{"key":"2026011502220648000_2.12.716.6","doi-asserted-by":"publisher","DOI":"10.5662\/wjm.v11.i4.116"},{"issue":"7","key":"2026011502220648000_2.12.716.7","doi-asserted-by":"crossref","first-page":"493","DOI":"10.5588\/ijtld.23.0161","article-title":"Launch of a second wave of IJTLD Clinical Standards for Lung Health","volume":"27","author":"Migliori","year":"2023","journal-title":"Int J Tuberc Lung Dis"},{"key":"2026011502220648000_2.12.716.8","doi-asserted-by":"crossref","first-page":"111485","DOI":"10.1016\/j.jclinepi.2024.111485","article-title":"Sample size in multistakeholder Delphi surveys: at what minimum sample size do replicability of results stabilize?","volume":"174","author":"Manyara","year":"2024","journal-title":"J Clin Epidemiol"},{"key":"2026011502220648000_2.12.716.9","unstructured":"World Health Organization . Global action plan on antimicrobial resistance. Geneva: WHO, 2015."},{"key":"2026011502220648000_2.12.716.10","unstructured":"World Health Organization . Global programme on tuberculosis & lung health. Geneva: WHO, 2015. https:\/\/www.who.int\/teams\/global-tuberculosis-programme\/the-end-tb-strategy."},{"key":"2026011502220648000_2.12.716.11","unstructured":"World Health Organization . Global antimicrobial resistance and use surveillance system (GLASS). Geneva: WHO, 2015. https:\/\/www.who.int\/initiatives\/glass."},{"key":"2026011502220648000_2.12.716.12","unstructured":"AMR Country Progress . Global database for tracking antimicrobial resistance (AMR) country self-assessment survey, 2025. https:\/\/new.amrcountryprogress.org."},{"key":"2026011502220648000_2.12.716.13","unstructured":"World Health Organization . Definitions and reporting framework for tuberculosis (2013 revision, updated december 2014 and january 2020). Geneva: WHO, 2013. https:\/\/www.who.int\/publications\/i\/item\/9789241505345."},{"key":"2026011502220648000_2.12.716.14","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00125511"},{"key":"2026011502220648000_2.12.716.15","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0012023"},{"issue":"5","key":"2026011502220648000_2.12.716.16","first-page":"Cd006591","article-title":"Patient education and counselling for promoting adherence to treatment for tuberculosis","volume":"2012","author":"M\u2019imunya","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"2026011502220648000_2.12.716.17","doi-asserted-by":"crossref","first-page":"e0314324","DOI":"10.1371\/journal.pone.0314324","article-title":"Impact of media coverage on the transmission dynamics of TB with vaccines and treatment","volume":"20","author":"Mulugeta","year":"2025","journal-title":"PLoS One"},{"issue":"2","key":"2026011502220648000_2.12.716.18","doi-asserted-by":"crossref","first-page":"cmae047","DOI":"10.1093\/fampra\/cmae047","article-title":"Can patient education initiatives in primary care increase patient knowledge of appropriate antibiotic use and decrease expectations for unnecessary antibiotic prescriptions?","volume":"42","author":"Hunter","year":"2025","journal-title":"Fam Pract"},{"key":"2026011502220648000_2.12.716.19","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(17)30325-0"},{"issue":"4","key":"2026011502220648000_2.12.716.20","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.cmi.2019.08.007","article-title":"How to start an antimicrobial stewardship programme in a hospital","volume":"26","author":"Mendelson","year":"2020","journal-title":"Clin Microbiol Infect"},{"issue":"1","key":"2026011502220648000_2.12.716.21","doi-asserted-by":"crossref","first-page":"dlab186","DOI":"10.1093\/jacamr\/dlab186","article-title":"What does antimicrobial stewardship look like where you are? Global narratives from participants in a massive open online course","volume":"4","author":"Nampoothiri","year":"2022","journal-title":"JAC Antimicrob Resist"},{"key":"2026011502220648000_2.12.716.22","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00109-2024"},{"key":"2026011502220648000_2.12.716.23","doi-asserted-by":"crossref","first-page":"S68","DOI":"10.1016\/j.ijid.2019.01.040","article-title":"Challenging MDR-TB clinical problems - The case for a new Global TB Consilium supporting the compassionate use of new anti-TB drugs","volume":"80s","author":"Tiberi","year":"2019","journal-title":"Int J Infect Dis"},{"issue":"10","key":"2026011502220648000_2.12.716.24","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.5588\/ijtld.18.0779","article-title":"Multidisciplinary advisory teams to manage multidrug-resistant tuberculosis: the example of the French Consilium","volume":"23","author":"Guglielmetti","year":"2019","journal-title":"Int J Tuberc Lung Dis"},{"issue":"1","key":"2026011502220648000_2.12.716.25","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1186\/s12890-021-01597-1","article-title":"Multidisciplinary management of difficult-to-treat drug resistant tuberculosis: a review of cases presented to the national consilium in Uganda","volume":"21","author":"Baluku","year":"2021","journal-title":"BMC Pulm Med"},{"issue":"2","key":"2026011502220648000_2.12.716.26","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.rppnen.2017.10.005","article-title":"Team approach to manage difficult-to-treat TB cases: Experiences in Europe and beyond","volume":"24","author":"D\u2019Ambrosio","year":"2018","journal-title":"Pulmonology"},{"key":"2026011502220648000_2.12.716.27","doi-asserted-by":"crossref","first-page":"1186905","DOI":"10.3389\/fphar.2023.1186905","article-title":"Clinical pharmacy services for tuberculosis management: a systematic review","volume":"14","author":"Iskandar","year":"2023","journal-title":"Front Pharmacol"},{"key":"2026011502220648000_2.12.716.28","doi-asserted-by":"crossref","first-page":"222","DOI":"10.3389\/fpubh.2019.00222","article-title":"Telemedicine in resource-limited settings to optimize care for multidrug-resistant tuberculosis","volume":"7","author":"Huang","year":"2019","journal-title":"Front Public Health"},{"key":"2026011502220648000_2.12.716.29","doi-asserted-by":"publisher","DOI":"10.1183\/23120541.00721-2020"},{"issue":"9","key":"2026011502220648000_2.12.716.30","doi-asserted-by":"crossref","first-page":"e3476","DOI":"10.1093\/cid\/ciaa857","article-title":"Model-based cost-effectiveness of state-level latent tuberculosis interventions in California, Florida, New York, and Texas","volume":"73","author":"Jo","year":"2021","journal-title":"Clin Infect Dis"},{"key":"2026011502220648000_2.12.716.31","unstructured":"World Health Organization . WHO consolidated guidelines on tuberculosis. Module 1: prevention \u2013 tuberculosis preventive treatment, 2nd ed. Geneva: WHO, 2024."},{"key":"2026011502220648000_2.12.716.32","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-publhealth-031912-114431"},{"key":"2026011502220648000_2.12.716.33","doi-asserted-by":"publisher","DOI":"10.1016\/s1473-3099(22)00153-0"},{"key":"2026011502220648000_2.12.716.34","unstructured":"World Health Organization . Report of the WHO consultation on asymptomatic tuberculosis. Geneva: WHO, 2024. pp. 14-15."},{"issue":"14","key":"2026011502220648000_2.12.716.35","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.1097\/QAD.0000000000003364","article-title":"The impact, effectiveness and outcomes of targeted screening thresholds for programmatic latent tuberculosis infection testing in HIV","volume":"36","author":"White","year":"2022","journal-title":"Aids"},{"issue":"1","key":"2026011502220648000_2.12.716.36","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1186\/s12916-020-01651-5","article-title":"The potential impact of preventive therapy against tuberculosis in the WHO South-East Asian Region: a modelling approach","volume":"18","author":"Mandal","year":"2020","journal-title":"BMC Med"},{"issue":"8","key":"2026011502220648000_2.12.716.37","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/S2213-2600(24)00083-3","article-title":"Effectiveness of preventive treatment among different age groups and Mycobacterium tuberculosis infection status: a systematic review and individual-participant data meta-analysis of contact tracing studies","volume":"12","author":"Martinez","year":"2024","journal-title":"Lancet Respir Med"},{"issue":"1","key":"2026011502220648000_2.12.716.38","doi-asserted-by":"crossref","first-page":"20","DOI":"10.5588\/ijtldopen.23.0342","article-title":"Screening of household contacts for TB infection in Cote d\u2019Ivoire","volume":"1","author":"N\u2019Guessan","year":"2024","journal-title":"IJTLD Open"},{"key":"2026011502220648000_2.12.716.39","unstructured":"World Health Organization . Technical report on critical concentrations for drug susceptibility testing of isoniazid and the rifamycins (rifampicin, rifabutin and rifapentine). Geneva: WHO, 2021."},{"key":"2026011502220648000_2.12.716.40","unstructured":"World Health Organization . Technical report on critical concentrations for drug susceptibility testing of medicines used in the treatment of drug-resistant tuberculosis. Geneva: WHO, 2018."},{"key":"2026011502220648000_2.12.716.41","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(22)00875-1"},{"key":"2026011502220648000_2.12.716.42","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc1413930"},{"key":"2026011502220648000_2.12.716.43","unstructured":"World Health Organization . WHO issues rapid communication on use of targeted next-generation sequencing for diagnosis of drug-resistant tuberculosis. Geneva: WHO, 2023. https:\/\/www.who.int\/news\/item\/25-07-2023-who-issues-rapid-communication-on-use-of-targeted-next-generation-sequencing-for-diagnosis-of-drug-resistant-tuberculosis."},{"key":"2026011502220648000_2.12.716.44","unstructured":"World Health Organization . Catalogue of mutations in Mycobacterium tuberculosis complex and their association with drug resistance. 2nd ed. Geneva: WHO, 2023."},{"issue":"2","key":"2026011502220648000_2.12.716.45","first-page":"190","article-title":"Regimens for drug-resistant tuberculosis","volume":"388","author":"Lange","year":"2023","journal-title":"N Engl J Med"},{"key":"2026011502220648000_2.12.716.46","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a017822"},{"key":"2026011502220648000_2.12.716.47","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccm.2019.08.001"},{"key":"2026011502220648000_2.12.716.48","doi-asserted-by":"publisher","DOI":"10.5588\/ijtld.23.0078"},{"key":"2026011502220648000_2.12.716.49","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(21)00808-2"},{"issue":"1","key":"2026011502220648000_2.12.716.50","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1186\/s40249-016-0187-9","article-title":"Tuberculosis care strategies and their economic consequences for patients: the missing link to end tuberculosis","volume":"5","author":"Getahun","year":"2016","journal-title":"Infect Dis Poverty"},{"key":"2026011502220648000_2.12.716.51","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmi.2023.07.013"},{"issue":"1","key":"2026011502220648000_2.12.716.52","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1038\/s41572-024-00504-2","article-title":"Multidrug-resistant tuberculosis","volume":"10","author":"Dheda","year":"2024","journal-title":"Nat Rev Dis Prim"},{"key":"2026011502220648000_2.12.716.53","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201711-2333OC"},{"key":"2026011502220648000_2.12.716.54","unstructured":"Raferty AM , Okada R , True L . Monitoring & case managment. In: Curry international tuberculosis center; drug-resistant tuberculosis: a survival guide for clinicians. 3rd ed. San Francisco, CA, USA: University of Califormia, 2022."},{"key":"2026011502220648000_2.12.716.55","unstructured":"World Health Organization . WHO consolidated guidelines on tuberculosis. Module 4: treatment and care. Geneva: WHO, 2025."},{"issue":"3","key":"2026011502220648000_2.12.716.56","doi-asserted-by":"crossref","first-page":"e0022721","DOI":"10.1128\/cmr.00227-21","article-title":"Tuberculosis treatment monitoring and outcome measures: new interest and new strategies","volume":"35","author":"Heyckendorf","year":"2022","journal-title":"Clin Microbiol Rev"},{"key":"2026011502220648000_2.12.716.57","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00804-2021"},{"key":"2026011502220648000_2.12.716.58","unstructured":"World Health Organization . WHO operational handbook on tuberculosis module 4: treatment \u2013 drug-susceptible tuberculosis treatment. Geneva: WHO, 2022."},{"issue":"3","key":"2026011502220648000_2.12.716.59","doi-asserted-by":"crossref","first-page":"e0223624","DOI":"10.1128\/spectrum.02236-24","article-title":"Discordance in genotypic and phenotypic drug susceptibility results: time to reconsider critical concentration of rifampicin","volume":"13","author":"Shrivas","year":"2025","journal-title":"Microbiol Spectr"},{"key":"2026011502220648000_2.12.716.60","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-018-0224-2"},{"key":"2026011502220648000_2.12.716.61","unstructured":"World Health Organization . Handbook for the use of digital technologies to support tuberculosis medication adherence. Geneva: WHO, 2017."},{"key":"2026011502220648000_2.12.716.62","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01126-2024"},{"key":"2026011502220648000_2.12.716.63","doi-asserted-by":"publisher","DOI":"10.1007\/s40265-014-0222-8"},{"issue":"10","key":"2026011502220648000_2.12.716.64","doi-asserted-by":"crossref","first-page":"772","DOI":"10.5588\/ijtld.22.0698","article-title":"Isoniazid and rifampicin exposure during treatment in drug-susceptible TB","volume":"27","author":"Akkerman","year":"2023","journal-title":"Int J Tuberc Lung Dis"}],"container-title":["IJTLD Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.5588\/ijtldopen.25.0522","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T10:24:59Z","timestamp":1768472699000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.theunion.org\/lookup\/doi\/10.5588\/ijtldopen.25.0522"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":64,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2025,12,1]]},"published-print":{"date-parts":[[2025,12]]}},"alternative-id":["10.5588\/ijtldopen.25.0522"],"URL":"https:\/\/doi.org\/10.5588\/ijtldopen.25.0522","relation":{},"ISSN":["3005-7590"],"issn-type":[{"value":"3005-7590","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12]]}}}